Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lipocine | LPCN | Nov 29, 2024 | 4.54 | +2.02 |
LiqTech International | LIQT | Nov 29, 2024 | 1.83 | -1.08 |
Liquidia | LQDA | Nov 29, 2024 | 11.55 | -0.56 |
Liquidity Services | LQDT | Nov 29, 2024 | 25.57 | +0.08 |
Lisata Therapeutics | LSTA | Nov 29, 2024 | 2.76 | -2.13 |
Lithia Motors | LAD | Nov 29, 2024 | 386.90 | +0.19 |
Lithium Americas | LAC | Nov 29, 2024 | 3.99 | +1.01 |
Lithium Americas (Argentina) | LAAC | Nov 29, 2024 | 3.38 | +2.42 |
Littelfuse | LFUS | Nov 29, 2024 | 246.67 | +0.34 |
LivaNova | LIVN | Nov 29, 2024 | 52.50 | +0.04 |
Live Nation Entertainment | LYV | Nov 29, 2024 | 138.25 | -1.06 |
Live Oak Bancshares | LOB | Nov 29, 2024 | 47.40 | -1.64 |
Live Ventures | LIVE | Nov 29, 2024 | 10.34 | +9.53 |
LiveOne | LVO | Nov 29, 2024 | 1.00 | +3.09 |
LivePerson | LPSN | Nov 29, 2024 | 0.97 | +2.36 |
LiveRamp | RAMP | Nov 29, 2024 | 30.36 | -0.26 |
LiveWire Group | LVWR | Nov 29, 2024 | 6.00 | +0.67 |
Lixiang Education ADR | LXEH | Nov 29, 2024 | 2.51 | +5.46 |
Lixte Biotechnology | LIXT | Nov 29, 2024 | 2.23 | +2.77 |
LKQ | LKQ | Nov 29, 2024 | 39.29 | +0.41 |
Lloyds Banking ADR | LYG | Nov 29, 2024 | 2.70 | +0.75 |
LM Funding America | LMFA | Nov 29, 2024 | 3.02 | +1.34 |
LMP Capital And Income Fund | SCD | Nov 29, 2024 | 17.83 | +1.54 |
LoanDepot A | LDI | Nov 29, 2024 | 2.25 | -2.17 |
Loar Holdings | LOAR | Nov 29, 2024 | 92.08 | +3.66 |
Lobo EV Technologies | LOBO | Nov 29, 2024 | 2.06 | -7.21 |
Locafy | LCFY | Nov 29, 2024 | 7.40 | +2.78 |
Local Bounti | LOCL | Nov 29, 2024 | 1.75 | +0.86 |
Lockheed Martin | LMT | Nov 29, 2024 | 529.41 | +0.70 |
Loews | L | Nov 29, 2024 | 86.73 | -0.37 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.